对于患有重度抑郁症的患者,鼻内胺:系统性审查和元分析
Soroush Oraee1, Mohammadreza Alinejadfard1, Hossein Golsorkh1
1School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Journal of psychiatric research
|November 10, 2024
概括
鼻腔内胺显著改善了重大抑郁症 (MDD) 和耐治疗抑郁症 (TRD) 的缓解和反应率. 这种快速起作用的治疗方法显示出安全性和耐受性,尽管长期影响需要进一步研究.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 大型抑郁症 (MDD) 影响全球数以百万计的人,许多人经历了治疗耐药性.
- 传统的抗抑郁药对很大一部分MDD患者是无效的,需要新的治疗方法.
- 埃斯凯特胺已成为治疗抑郁症的有希望的快速作用干预药物.
研究的目的:
- 评估MDD和治疗耐药抑郁症 (TRD) 患者鼻内素的疗效和安全性.
- 通过对现有临床试验进行元分析,综合现有证据.
主要方法:
- 在PubMed,EMBASE和Cochrane图书馆进行了全面的文献搜索,截至2024年1月15日.
- 九项涉及1752名患者的研究被纳入了元分析,使用随机效应模型.
- 通过缓解和响应率来评估有效性,风险比率 (RR) 作为效果大小.
主要成果:
- 与安慰剂相比,鼻腔内斯基坦胺显著增加了缓解率 (RR = 1.371,p < 0.0001).
- 观察到,用鼻腔内注射石胺治疗的反应率高于安慰剂 (RR = 1.274,p = 0.001).
- 84毫克的剂量和灵活的剂量显示出特别有效;不良事件通常是可以容忍的.
结论:
- 鼻腔内注射的斯基坦胺在改善MDD和TRD患者的抑郁症状方面是有效的.
- 该疗法显示出良好的安全性和耐受性.
- 建议进行进一步的研究,以探索特定患者子组的长期结果和疗效.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
195
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
195
01:30Electroconvulsive Therapy
25
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
25
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
316
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
316
01:25Antidepressant Drugs: Overview
365
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
365
01:18Depression: Overview
219
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
219